Assertio Holdings (ASRT) Receivables - Net (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Receivables - Net came in at $61.5 million in Q1 2026, down 7.19% year-on-year from $66.3 million in Q1 2025, and down 48.77% quarter-over-quarter from $120.1 million in Q4 2025.
Assertio Holdings (ASRT) Receivables - Net (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Receivables - Net across 8 years of filings, most recently posting $61.5 million for Q1 2026.
- Receivables - Net for Q1 2026 came in at $61.5 million, down 7.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.5 million (down 7.19% YoY), and the FY2025 annual result was $120.1 million, up 121.93% from the prior year.
- Receivables - Net came in at $61.5 million for Q1 2026 at Assertio Holdings, down from $120.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $141.3 million in Q3 2025 to a low of $39.9 million in Q2 2024.
- The 5-year median for Receivables - Net is $48.5 million (2022), against an average of $59.9 million.
- Across the five-year window, Receivables - Net retreated 28.05% in 2024 and soared 214.41% in 2025, its largest moves.
- Assertio Holdings' Receivables - Net stood at $45.4 million in 2022, then advanced by 5.08% to $47.7 million in 2023, then increased by 13.55% to $54.1 million in 2024, then surged by 121.93% to $120.1 million in 2025, then plunged by 48.77% to $61.5 million in 2026.
- The last three Receivables - Net figures came in at $61.5 million (Q1 2026), $120.1 million (Q4 2025), and $141.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.53 Mn |
| Mar 31, 2026 | 61.53 Mn |
| Dec 31, 2025 | 120.11 Mn |
| Dec 31, 2025 | 120.11 Mn |
| Sep 30, 2025 | 141.31 Mn |
| Sep 30, 2025 | 141.31 Mn |
| Jun 30, 2025 | 61.09 Mn |
| Jun 30, 2025 | 61.09 Mn |
| Mar 31, 2025 | 66.29 Mn |
| Mar 31, 2025 | 66.29 Mn |
| Dec 31, 2024 | 54.12 Mn |
| Dec 31, 2024 | 54.12 Mn |
| Sep 30, 2024 | 44.94 Mn |
| Sep 30, 2024 | 44.94 Mn |
| Jun 30, 2024 | 39.91 Mn |
| Jun 30, 2024 | 39.91 Mn |
| Mar 31, 2024 | 42.61 Mn |
| Mar 31, 2024 | 42.61 Mn |
| Dec 31, 2023 | 47.66 Mn |
| Dec 31, 2023 | 47.66 Mn |